US Stock MarketDetailed Quotes

Moderna (MRNA)

Watchlist
  • 50.600
  • +0.960+1.93%
Trading Jun 12 11:50 ET
20.08BMarket Cap-6.22P/E (TTM)

Moderna (MRNA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
263.55%389M
-39.92%1.92B
-29.29%676M
-45.98%1B
-38.01%137M
-35.93%107M
-52.64%3.2B
-66.01%956M
3.81%1.86B
-30.06%221M
Operating revenue
233.33%350M
-26.85%3.3B
-7.63%1.05B
-33.50%1.97B
-7.85%176M
-52.70%105M
-44.93%4.52B
-73.64%1.14B
68.70%2.96B
-34.81%191M
Cost of revenue
961.11%955M
-40.71%868M
-38.84%452M
-59.73%207M
3.48%119M
-6.25%90M
-68.80%1.46B
-20.45%739M
-77.06%514M
-84.27%115M
Gross profit
-3,429.41%-566M
-39.25%1.05B
3.23%224M
-40.72%795M
-83.02%18M
-76.06%17M
-15.82%1.74B
-88.48%217M
395.37%1.34B
125.54%106M
Operating expense
-22.96%822M
-27.32%4.13B
-26.11%1.08B
-25.23%1.06B
-37.03%925M
-20.19%1.07B
-9.84%5.68B
-22.10%1.46B
-9.44%1.41B
1.17%1.47B
Selling and administrative expenses
-18.40%173M
-13.29%1.02B
-12.25%308M
-4.63%268M
-14.18%230M
-22.63%212M
-24.21%1.17B
-25.32%351M
-36.43%281M
-19.28%268M
Research and development costs
-24.18%649M
-31.06%3.13B
-30.93%775M
-29.55%801M
-42.67%700M
-19.47%856M
-6.23%4.54B
-20.20%1.12B
-1.98%1.14B
6.36%1.22B
Other operating expenses
----
40.54%-22M
80.00%-2M
-100.00%-14M
75.00%-5M
---1M
60.64%-37M
-600.00%-10M
84.09%-7M
28.57%-20M
Operating profit
-32.19%-1.39B
22.08%-3.07B
31.22%-857M
-271.43%-260M
33.46%-907M
17.06%-1.05B
6.94%-3.95B
-20,866.67%-1.25B
96.52%-70M
27.00%-1.36B
Net non-operating interest income expense
-38.20%55M
-24.19%304M
-27.06%62M
-24.74%73M
-23.81%80M
-21.93%89M
-4.75%401M
-37.04%85M
2.11%97M
15.38%105M
Non-operating interest income
-20.00%72M
-26.12%314M
-23.08%70M
-29.13%73M
-27.03%81M
-25.00%90M
0.95%425M
-11.65%91M
-1.90%103M
6.73%111M
Non-operating interest expense
1,600.00%17M
-58.33%10M
33.33%8M
--0
-83.33%1M
-83.33%1M
-36.84%24M
0.00%6M
-40.00%6M
-53.85%6M
Other net income (expense)
66.67%-1M
103.17%2M
82.61%-4M
142.86%9M
76.92%-3M
49.19%-63M
67.61%-23M
85.37%-6M
-177.78%-21M
Gain on sale of security
85.71%-1M
91.07%-5M
77.78%-2M
144.44%4M
----
53.33%-7M
22.22%-56M
59.09%-9M
75.68%-9M
-204.55%-23M
Other non- operating income (expenses)
----
200.00%7M
85.71%-2M
-233.33%-4M
350.00%9M
100.00%4M
94.35%-7M
88.43%-14M
175.00%3M
-60.00%2M
Income before tax
-38.38%-1.33B
23.26%-2.77B
32.52%-799M
-990.48%-187M
36.04%-818M
17.25%-964M
8.50%-3.61B
-1,791.43%-1.18B
101.07%21M
26.87%-1.28B
Income tax
28.57%9M
217.39%54M
142.19%27M
62.50%13M
7M
-30.00%7M
-105.96%-46M
56.46%-64M
-99.52%8M
0
Net income
-38.31%-1.34B
20.75%-2.82B
26.25%-826M
-1,638.46%-200M
35.50%-825M
17.36%-971M
24.46%-3.56B
-616.13%-1.12B
100.36%13M
7.32%-1.28B
Net income continuous Operations
-38.31%-1.34B
20.75%-2.82B
26.25%-826M
-1,638.46%-200M
35.50%-825M
17.36%-971M
24.46%-3.56B
-616.13%-1.12B
100.36%13M
7.32%-1.28B
Minority interest income
Net income attributable to the parent company
-38.31%-1.34B
20.75%-2.82B
26.25%-826M
-1,638.46%-200M
35.50%-825M
17.36%-971M
24.46%-3.56B
-616.13%-1.12B
100.36%13M
7.32%-1.28B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.31%-1.34B
20.75%-2.82B
26.25%-826M
-1,638.46%-200M
35.50%-825M
17.36%-971M
24.46%-3.56B
-616.13%-1.12B
100.36%13M
7.32%-1.28B
Basic earnings per share
-34.92%-3.4
21.77%-7.26
27.49%-2.11
-1,800.00%-0.51
36.04%-2.13
17.92%-2.52
24.74%-9.28
-610.53%-2.91
100.31%0.03
8.01%-3.33
Diluted earnings per share
-34.92%-3.4
21.77%-7.26
27.49%-2.11
-1,800.00%-0.51
36.04%-2.13
17.92%-2.52
24.74%-9.28
-629.09%-2.91
100.31%0.03
8.01%-3.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 263.55%389M-39.92%1.92B-29.29%676M-45.98%1B-38.01%137M-35.93%107M-52.64%3.2B-66.01%956M3.81%1.86B-30.06%221M
Operating revenue 233.33%350M-26.85%3.3B-7.63%1.05B-33.50%1.97B-7.85%176M-52.70%105M-44.93%4.52B-73.64%1.14B68.70%2.96B-34.81%191M
Cost of revenue 961.11%955M-40.71%868M-38.84%452M-59.73%207M3.48%119M-6.25%90M-68.80%1.46B-20.45%739M-77.06%514M-84.27%115M
Gross profit -3,429.41%-566M-39.25%1.05B3.23%224M-40.72%795M-83.02%18M-76.06%17M-15.82%1.74B-88.48%217M395.37%1.34B125.54%106M
Operating expense -22.96%822M-27.32%4.13B-26.11%1.08B-25.23%1.06B-37.03%925M-20.19%1.07B-9.84%5.68B-22.10%1.46B-9.44%1.41B1.17%1.47B
Selling and administrative expenses -18.40%173M-13.29%1.02B-12.25%308M-4.63%268M-14.18%230M-22.63%212M-24.21%1.17B-25.32%351M-36.43%281M-19.28%268M
Research and development costs -24.18%649M-31.06%3.13B-30.93%775M-29.55%801M-42.67%700M-19.47%856M-6.23%4.54B-20.20%1.12B-1.98%1.14B6.36%1.22B
Other operating expenses ----40.54%-22M80.00%-2M-100.00%-14M75.00%-5M---1M60.64%-37M-600.00%-10M84.09%-7M28.57%-20M
Operating profit -32.19%-1.39B22.08%-3.07B31.22%-857M-271.43%-260M33.46%-907M17.06%-1.05B6.94%-3.95B-20,866.67%-1.25B96.52%-70M27.00%-1.36B
Net non-operating interest income expense -38.20%55M-24.19%304M-27.06%62M-24.74%73M-23.81%80M-21.93%89M-4.75%401M-37.04%85M2.11%97M15.38%105M
Non-operating interest income -20.00%72M-26.12%314M-23.08%70M-29.13%73M-27.03%81M-25.00%90M0.95%425M-11.65%91M-1.90%103M6.73%111M
Non-operating interest expense 1,600.00%17M-58.33%10M33.33%8M--0-83.33%1M-83.33%1M-36.84%24M0.00%6M-40.00%6M-53.85%6M
Other net income (expense) 66.67%-1M103.17%2M82.61%-4M142.86%9M76.92%-3M49.19%-63M67.61%-23M85.37%-6M-177.78%-21M
Gain on sale of security 85.71%-1M91.07%-5M77.78%-2M144.44%4M----53.33%-7M22.22%-56M59.09%-9M75.68%-9M-204.55%-23M
Other non- operating income (expenses) ----200.00%7M85.71%-2M-233.33%-4M350.00%9M100.00%4M94.35%-7M88.43%-14M175.00%3M-60.00%2M
Income before tax -38.38%-1.33B23.26%-2.77B32.52%-799M-990.48%-187M36.04%-818M17.25%-964M8.50%-3.61B-1,791.43%-1.18B101.07%21M26.87%-1.28B
Income tax 28.57%9M217.39%54M142.19%27M62.50%13M7M-30.00%7M-105.96%-46M56.46%-64M-99.52%8M0
Net income -38.31%-1.34B20.75%-2.82B26.25%-826M-1,638.46%-200M35.50%-825M17.36%-971M24.46%-3.56B-616.13%-1.12B100.36%13M7.32%-1.28B
Net income continuous Operations -38.31%-1.34B20.75%-2.82B26.25%-826M-1,638.46%-200M35.50%-825M17.36%-971M24.46%-3.56B-616.13%-1.12B100.36%13M7.32%-1.28B
Minority interest income
Net income attributable to the parent company -38.31%-1.34B20.75%-2.82B26.25%-826M-1,638.46%-200M35.50%-825M17.36%-971M24.46%-3.56B-616.13%-1.12B100.36%13M7.32%-1.28B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.31%-1.34B20.75%-2.82B26.25%-826M-1,638.46%-200M35.50%-825M17.36%-971M24.46%-3.56B-616.13%-1.12B100.36%13M7.32%-1.28B
Basic earnings per share -34.92%-3.421.77%-7.2627.49%-2.11-1,800.00%-0.5136.04%-2.1317.92%-2.5224.74%-9.28-610.53%-2.91100.31%0.038.01%-3.33
Diluted earnings per share -34.92%-3.421.77%-7.2627.49%-2.11-1,800.00%-0.5136.04%-2.1317.92%-2.5224.74%-9.28-629.09%-2.91100.31%0.038.01%-3.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More